Seeing Is Believing
Currently, out of the existing stock ratings of Stephen Willey - 123 which are a Buy (70.29%), 51 which are a Hold (29.14%), 1 which are a Sell (0.57%)
Analyst Stephen Willey works at STIFEL and is covering the Healthcare sector with 324 price targets and ratings displayed on 45 stocks.
Stephen Willey's average stock forecast success ratio is 52.53% with an average time for price targets to be met of 163.77 days.
Most recent stock forecast was given on IGMS, IGM Biosciences at 14-Nov-2023.
Analyst best performing recommendations are on MGNX (MACROGENICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 5/6/2020. The price target of $21 was fulfilled within 1 day with a profit of $4.15 (16.5%) receiving and performance score of 165.01.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
3
$-0.48 (-13.79%)
6
1 years 6 months 17 days ago
4/5 (80%)
$0.04 (-0.68%)
4
Hold
5
$1.52 (43.68%)
9
1 years 6 months 21 days ago
1/2 (50%)
$-1.45 (23.65%)
6
Hold
10
$6.52 (187.36%)
10
1 years 11 months 6 days ago
2/2 (100%)
$1.75 (21.43%)
46
Buy
40
1 years 11 months 18 days ago
1/1 (100%)
$6.16 (18.20%)
3
Which stock is Stephen Willey is most bullish on?
Which stock is Stephen Willey is most reserved on?
What Year was the first public recommendation made by Stephen Willey?